Coffee as a speciality and functional beverage

Functional and Speciality Beverage Technology

Volumn , Issue , 2009, Pages 370-395

  Farah, A ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 75149147941     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845695569.3.370     Document Type: Chapter

References (111)

1. Abic Brazilian Association of Coffee Industry (Technical information) 2007.
2. Abics Brazilian Association of Instant Coffee Industry (Technical information) 2007.
3. Adams M.R., Dougan J. Waste products. In: Coffee. Vol 2 Technology 1987, Elsevier Science, New York. R.J. Clarke, R. Macrae (Eds.).
4. Agardh E.E., Carlsson S., Ahlbom A., Efendic S., Grill V., Hammar N., Hilding A., Ostenson C.G. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J. Intern. Med. 2004, 255:645-652.
5. Andrade-Cetto A., Wiedenfeld H. Hypoglycemic effect of Cecropia obtusifo-lia on streptozotocin diabetic rats. J. Ethnopharmacol. 2001, 78:145-149.
6. Arion W.J., Canfield W.K., Ramos F.C., Schinder P.W., Burger H.J., Hemmerle H., Schubert G., Below P., Herling A.W. Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose-6-phosphatase. Arch. Biochem. Biophys. 1997, 339:315-322.
7. Aruoma O.I. Antioxidant actions of plant foods: use of oxidative DNA damage as a tool for studying antioxidant efficacy. Free Radic Res 1999, 30(6):419-427.
8. Association For Science And Information On Coffee (ASIC): . http://www.asic-cafe.org.
9. Balyaya K.J., Clifford M.N. Chlorogenic acids and caffeine contents of mon-sooned Indian arabica and robusta coffees compared with wet and dry processed coffees from the same geographic area. In Proc 16th Coll Int Chem Coffee 1995, ASIC, Paris, p. 316-325.
10. Basnet P., Matsushige K., Hase K., Kadota S., Namba T. Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol. Pharm. Bull. 1996, 19(11):1479-1484.
11. Bee S., Brando C.H.J., Brumen G., Carvalhaes N., Kolling-Speer I., Speer K., Liverani F.S., Teixeira A.A., Teixeira R., Thomaziello R.A., Viani R., Vitzthum O.G. The raw bean. Espresso Coffee, The Science of Quality 2005, 87-178. Elsevier Academic Press, Italy. A. Illy, R. Viani (Eds.).
12. Bennat C., Engelhardt U.H., Kiehne A., Wirries F., Maier H.G. HPLC analysis of chlorogenic acid lactones in roasted coffee. Z. Lebensm. Unters. Forsch. 1994, 199:17-21.
13. Bravi F., Bosetti C., Tavani A., Bagmardi V., Gallees S., Negri E., Fauschi S., La Vecchia C. Coffee drinking and hepatocellular carcinoma risk: a meta analysis. Hepatology 2007, 46(2):430-435.
14. Caballero B., Trugo L.C., Fi Nglas P. Encyclopedia of Food Science and Nutrition 2003, Vol 3. Academic Press, Oxford.
15. Cavin C., Holzhaeuser D., Scharf G., Constable A., Huber W.W., Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food and Chem. Toxicol. 2002, 40:1155-1163.
16. Chiang L.C., Chiang W., Chang M.Y., Ng L.T., Lin C.C. Antiviral activity of Plantago major extracts and related compounds in vitro. Antiviral Res. 2002, 55:53-62.
17. Clarke R.J. Coffee: green coffee / roast and ground In: Encyclopedia of Food Science and Nutrition Ed. Caballero B, Trugo, LC, Finglas, P 2003, Vol 3.. Academic Press, Oxford. 2nd Edition.
18. Coffee: Chemistry 1985, Vol. 1. Barking, Elsevier. R.J. Clarke, R. Macrae (Eds.).
19. Coffee: Technology 1987, Vol. 2. Barking, Elsevier. R.J. Clarke, R. Macrae (Eds.).
20. Clifford M.N. The nature of chlorogenic acids. Are they advantageous compounds in coffee? In Proc 17th Int. Sci. Coll. Coffee (Nairobi) 1997, 79-91. ASIC, Paris.
21. Clifford M.N. Chlorogenic acids and other cinnamates - nature, occurrence, dietary burden, absorption and metabolismu J. Sci. Food Agric. 2000, 80:1033-1043.
22. Coffee: Botany, Biochemistry, Production of Beans and Beverage 1985, Chapman and Hall, London. M.N. Clifford, K.C. Wilson (Eds.).
23. Coffee Board Of India 2007, http://www.indiacoffee.org/default.htm.
24. Daglia M., Cuzzoni M.T., Dacarro C. Antibacterial activity of coffee. J. Agric. Food Chem. 1994, 42:2270-2272.
25. Daglia M., Papetti A., Gregotti C., Bertè F., Gazzani G. In vitro antioxidant and ex vivo protective activities of green and roasted coffee. J. Agric. Food Chem. 2000, 48:1449-1454.
26. Debry G. Coffee and Health 1994, John Libbey Eurotext, London.
27. De Paulis T., Martin P.R. Cerebral effects of noncaffeine constituents in roasted coffee. Coffee Tea, Chocolate and Brain 2004, Taylor & Francis, London. A. Nehligh (Ed.).
28. Del Castillo M.D., Ames J.M., Gordon M. Effect of roasting on the antioxidant activity of coffee brews. J. Agric. Food Chem. 2002, 50:3698-3703.
29. Demirbag D., Ozdemir F., Ture M. Effects of coffee consumption and smoking habit on bone mineral density. Rheumatol. Int. 2006, 26:530-535.
30. Dri Dietary Reference Intakes. Institute of Medicine 2000, National Academy Press, Washington, DC.
31. Farah A. Distribuição nos grãos, influência sobre a qualidade da bebida e biodisponibilidade dos ácidos clorogênicos do café. Instuto de Química 2004, Universidade Federal do Rio de Janeiro, RJ, Brasil, Doctorate Thesis.
32. Farah A., Donangelo C.M. Phenolic compounds in coffee. Braz. J. Plant Physiol. 2006, 18:23-36.
33. Farah A., Neves D.F., Trugo L.C., Rosenthal A., Della Modesta R.C. Compostos fenólicos em café torrado 2001, In Annals of the II Simpósio de PNP&D Embrapa Café. Vitória, ES, Brazil, pp. 1144-1149.
34. Farah A., De Paulis T., Trugo L.C., Martin P.R. Effect of roasting on the formation of chlorogenic acid lactones. J. Agric. Food Chem. 2005, 53:1505-1513. 10.1021/jf048701t.
35. Farah A., De Paulis T., Trugo L.C., Martin P.R. Chlorogenic acids and lactones in regular and water-decaffeinated arabica coffee. J Agric Food Chem. 2006, 54:374-381. 10.1021/jf0518305.
36. Farah A., Monteiro M., Calado V., Trugo L.C. Correlation between the chemical attributes of coffee and cup quality. Food Chem. 2006, 98:373-380. 10.1016/j.foodchem.2005.07.032.
37. Farah A., Shearer J., De Paulis T. Diferuloylquinide is converted to diferu-loylquinic acid and other phenolic compounds during digestion and/or metabolism in rats. 3rd International Conference on Polyphenols and Health 2007, Kyoto, Japan, Nov 25-28.
38. Fda Code of Federal Regulations. Title 21, Vol. 3 2006, Accessed 19 September 2007. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=173.255.
39. Flament I. Coffee Flavor Chemistry 2002, John Wiley & Sons, Ltd, Chichester.
40. Flores G.B., Andrade F., Lima D.R. Can coffee help fighting the drug problem?. Preliminary results of a Brazilian youth drug study. Acta Pharmacol. Sin. 2000, 21(12):1059-1070.
41. Gerin I., Van Schaftingen E. Evidence for glucose-6-phosfate transport in rat liver microssomes. FEBS Letters 2002, 517:257-260.
42. Ginz M., Balzer H.H., Bradbury A.G.W., Maier H.G. Formation of aliphatic acids by carbohydrate degradation during roasting of coffee. Eur. Food Res Technol. 2000, 211:404-410.
43. Gntechwitz D., Reichrdt N., Blaut M., Steinhart H., Bunzel M. Dietary fiber from coffee beverage: degradation by human fecal microbiota. J. Agric. Food Chem. 2007, 55:6989-6996.
44. Hemmerle H., Burger H.J., Bellow P., Schubert G., Rippel R., Schindler P.W., Paulus E., Herling A. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J. Med. Chem. 1997, 40:137-145.
45. Herling A.W., Burger H.J., Schwab D., Hemmerle H., Below P., Schubert G. Pharmacodynamic profile of a novel inhibitor of the hepatic glucose-6-phosphatase system. Am. J. Physiol. 1998, 274:G1087-G1093.
46. Herrera-Arellano A., Aguilar-Santamaria L., Garcia-Hernandez B., Nicasio-Torres P., Tortoriello J. Clinical trial of Cecropia obtusifolia and Marrubium vulgare leaf extracts on blood glucose and serum lipids in type 2 diabetics. Phytomedicine 2004, 11:561-566.
47. Homma S., Murata M. Characterization of metal-chelating compounds in instant coffee 1995, In Sixième Colloque Scientifique International sur le Café. Association Scientifique International du Café, Kyoto, Japan, pp. 183-191.
48. Huang M.T., Chang R.L., Wood A.W., Newmark H.L., Sayer J.M., Yagi H., Jerina D.M., Conney A.H. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis 1985, 6:237-242.
49. Ice (INTERCONTINENTAL EXCHANGE) 2008, Accessed 14 April 2008. http://www.theice.com/coffee.htm.
50. Ico 2007, Accessed 9 December 2007. http://www.ico.org/prices/po.htm.
51. Espresso Coffee. The Science of Quality 2005, Elsevier, London. 2nd. A. Illy, R. Viani (Eds.).
52. International Coffee Organization (ICO): . http://www.ico.org.
53. Johnston K.L., Clifford M., Morgan L.M. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am. J. Clin. Nutr. 2003, 78:728-733.
54. Kasai H., Fukada S., Yamaizumi Z., Sugie S., Mori H. Action of chlorogenic acid in vegetables and fruits as an inhibitor of 8-hydroxydeoxyguanosine formation in vitro and in rat carcinogenesis model. Food Chem. Toxicol. 2000, 38:467-471.
55. Kölling-Speer L., Speer K. The raw bean composition. Espresso Coffee,the Science of Quality 2005, 148-178. ElsevierAcademic Press, Italy. A. Illy, R. Viani (Eds.).
56. Kyng P.J., Ma G., Miao W., Jia Q., Mcdougall B.R., Reinecele M.G., Cornel C., Kuan J., Kim T., Robinson W.E. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication. J. Med. Chem. 1999, 42(3):497-509.
57. Larsson S.C., Wolk A. Coffee consumption and risk of liver cancer: a meta analysis. Gastroenterology 2007, 132:1740-1745.
58. Ledl F., Schleicher E. New aspects of the Maillard reaction in foods and in human body. Angew. Chem. Int. 1990, 29:565-594.
59. Lee C. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL, peroxidation. Clin. Chim. Acta 2000, 295:141-154.
60. Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G.B., Mcdowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am. J. Epidemiol. 2002, 156:445-453.
61. Lo H.H., Chung J.G. The effects of plant phenolics, caffeic acid, chlorogenic acid and ferulic acid on arylamine N-acetyltransferase activities in human gastrointestinal microflora. Anticancer Res. 1999, 19:133-140.
62. Maier H.G. Status of research in the field of non-volatile coffee components. In Proc 15th Coll Sci Int Café, Montpellier 1994, 567-576. ASIC, Paris, France.
63. Mazzafera P. Trigonelline in coffee. Phytochemistry 1991, 30(7):2309-2310.
64. Mc Dougall B., King P.J., Wu B.W., Hostomsky Z., Reinecke M.G., Robinson W.E. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase. Antimicrob. Agents Chemother. 1998, 42:140-146.
65. Mori H., Tanaka T., Shima H., Kuniasu T., Takahashi M. Inhibitory effect of chlorogenic acid on methilazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters. Cancer Letters 1986, 30:49-54.
66. Mori H., Sugie S., Tanaka T., Makita H., Yoshimi N. Supressive effects of natural antioxidants on carcinogenesis in digestive organs. Environm. Mutagen. Res. Commun. 1996, 18:73-77.
67. Namiki M. Antioxidants/antimutagens in food. Crit. Rev. Food Sci. Nutr. 1990, 29:273-300.
68. Natella F., Nardini M., Giannetti I., Dattilo C., Scaccini C. Coffee drinking influences plasma antioxidant capacity in humans. J. Agric. Food Chem. 2002, 50:6211-6216.
69. Natella F., Scaccini C. Does coffee drinking influence plasma antioxidant activity? Proc 19th Int 2001, Conf. Coffee Sci, ASIC, Trieste, Italy.
70. National Coffee Association Of Usa (NCA): . http://www.ncausa.org.
71. Nehlig A. Exploring biotechnology. Chemtech. 1999, 29(7):30-35.
72. Nicoli M.C., Anese M., Manzocco L., Lerici C.R. Antioxidant properties of coffee brews in relation to the roasting degree. Lebensm.-Wissens.-Tech. 1997, 30(3):292-297.
73. Ogita S., Uefugi H., Yamaguchi Y., Koizumi N., Sano H. Producing decaffeinated coffee plants. Nature 2003, 423:823.
74. Olthof M.R., Hollman P.C., Zoch P.L., Katan M.B. Consumption of high doses of chlorogenic acid, present in coffee or black tea increases plasma total homo-cysteine concentration in humans, Am. J. Clin. Nutr. 2001, 73:532-538.
75. Pannala A., Razaq R., Halliwell B., Singh S., Rice Evans C. Inhibition of peroxynitrite dependent tyrosine nitration by hydroxycinnamates: nitration or electron donation? Free Radical Biol. Med. 1998, 24:594-606.
76. Pellegrini N., Serafini M., Colombi B., Del Rio D., Salvatore S., Bianchi M., Brighenti F. Total antioxidant capacity of plant foods, beverages and oils consumed in Italy assessed by three different in vitro assays. J. Nutr. 2003, 133:2812-2819.
77. Perrone D., Donangelo C.M., Farah A. Fast simultaneous analysis of caffeine, trigonelline, nicotinic acid and sucrose in coffee by liquid chromatography-mass spectrometry. Food Chemistry 2008, 106:859-867.
78. Ranheim T., Halvorsen B. Coffee consumption and human health - beneficial or detrimental? Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol. Nutr. Food Res. 2005, 49:274-284.
79. Ribeiro-Alves M., Trugo L.C., Donangelo C. Use of oral contraceptives blunts the calciuric effect of caffeine in young adult women. J. Nutr. 2003, 133:393-398.
80. Robinson W.E., Cordeiro M., Abdel-Malek S., Jia Q., Chow S.A., Reinecke M.G., Mitchell W.M. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain. Mol. Pharmacol. 1996, 50:846-855.
81. Robinson W.E., Reinecke M.G., Abdel-Malek S., Jia Q., Chow S.A. Inhibitors of HIV-1 replication that inhibit HIV integrase. Proc. Natl Acad. Sci. 1996, 93:6326-6331.
82. Romani S., Pinnavaia G.G., Rosa M.D. Influence of roasting levels on Ocratoxin A content in coffee. J. Agric. Food. Chem. 2003, 51:5168-5171.
83. Rosengreen A., Doterval A., Wilhelmsen L., Thele D., Johanssens S. Coffee and incidence of diabetes in Sweedish women: a perspective 18-year follow-up study. Intern. Med. 2004, 255:89-95.
84. Salazar-Martinez E., Willett W.C., Ascherio A., Manson J.E., Leitzmann M.F., Stampfer M.J., Hu F.B. Coffee consumption and risk for type 2 diabetes mellitus. Ann. Intern. Med. 2004, 140:1-8.
85. Schrader K., Kiehne A., Engelhardt U.H., Maier R.H.G. Determination of chlo-rogenic acids with lactones in roasted coffee. J. Sci. Food Agric. 1996, 71:392-398.
86. Shearer J., Farah A., De Paulis T., Bracy D.P., Pencek R.R., Graham T.E., Wasserman D.H. Quinides of roasted coffee enhance insulin action in conscious rats. J. Nutr. 2003, 133:3529-3532.
87. Shearer J., Sellars E., Farah A., Graham T.E., Wasserman D.H. Effects of chronic coffee consumption on glucose kinetics in the conscious rat. Can. J. Phys. Pharm. 2007, 85:823-830.
88. Shlonsky A.K., Klatsky A., Armstrong A. Traits of persons who drink decaffeinated coffee. Ann. Epidemiol. 2003, 13(4):273-279.
89. Silvarola M.B., Mazzafera P., Fazioli L.C. A naturally decaffeinated arabica coffee. Nature 2004, 249:826.
90. Soares C., Farah A., Fernandes F., Fernandes J.O. Influence of the roasting conditions on the formation of acrylamide in Brazilian coffee: preliminary results. In Proc. 22nd International Conference on Coffee Science, Campinas, São Paulo, Brazil 2008, ASIC, Paris, France.
91. Soriguer F., Rojo-Martinez G., De Antonio I.E. Coffee consumption and type 2 diabetes mellitus. Ann Intern Med. 2004, 17(141):321-323. author reply 3-4.
92. Speciality Coffee Association Of America (SCAA): . http://www.scaa.org.
93. Steinhart H., Luger A. An analytical distinction between untreated and steam-treated roasted coffee. In Proc. of 17th Int. Sci. Coll. on Coffee (Nairobi) 1997, 155-160. ASIC, Paris.
94. Stephanucci A., Clinton W.P., Hamel M., Kirk J.L., Othmer D.F. Encyclopedia of Chemical Technology, Vol. 6 1979, 511-512. Wiley, New York.
95. Stich H.F., Rosin M.P., Bryson L. Inhibition of mutagenicity of a model nitrosa-tion reaction by naturally occurring phenolics, coffee and tea. Mutation Res. 1982, 95:119-128.
96. Svilaas A., Sakhi A.K., Andersen L.F., Svilaas T., Strom E.C., Jacobs D.R., Ose L., Blomhoffr R. Intakes of antioxidants in coffee, wine and vegetables are correlated with plasma carotenoids in humans. J. Nutr. 2004, 134:562-567.
97. Taniwaki M.H., Pitt J.I., Teixeira A.A., Iamanaka B.T. The source of ocratoxin A in Brazilian coffee and its formation in relation to processing methods. Int. J. Food. Microbiol. 2003, 82:173-179.
98. Tatefuji T., Izumi N., Ohta T., Arai S., Ikeda M., Kurimoto M. Isolation and identification of compounds from Brazilian propolis which enhance macrophage spreading and mobility. Biol. Pharm. Bull. 1996, 19(7):966-970.
99. Toci A.T., Farah A. Volatile compounds as potential defective coffee beans'markers. Food Chem. 2008, 108:1133-1141.
100. Toci A.T., Farah A.F., Trugo L.C. Efeito do processo de descafeinação com diclorometano sobre a composição química dos cafés Arábica e Robusta antes e após a torração. Química Nova 2006, 29(5):965-971.
101. Trugo L. Coffee analysis In Encyclopedia of Food Science and Nutrition, Ed. Caballero B, Trugo LC, Finglas P 2003, Vol 3.. Academic Press, Oxford. 2nd Edition.
102. Trugo L.C., Macrae R. A study of the effect of roasting on the chlorogenic acid composition of coffee using HPLC. Food Chem. 1984, 15:219-227.
103. Trugo L.C., Macrae R. Chlorogenic acid composition of instant coffees. Analyst 1984, 109:263-266.
104. Van Dam R.M., Willett W.C., Manson J.E., Hu F.B. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 2006, 29:398-403.
105. Variyar P.S., Ahmad R., Bhat R., Niyas Z., Sharma A. Flavouring components of raw monsooned arabica coffee and their changes during radiation processing. J. Agric. Food Chem. 2003, 51:7945-7950.
106. Viani R. The composition of coffee. In Caffeine, Coffee and Health 1993, Haven, New York.
107. Vinson J. The 230th ACS National Meeting. Polyphenols: total amounts of foods and beverages and US capita consumption, Washington, DC 2005.
108. Wattenberg L.W. Inhibition of neoplasia by minor dietary constituents. Cancer Res. (suppl.) 1983, 43:2448s-2453s.
109. Wattenberg L.W., Coccia J.B., Lk Lam Inhibitory effects of phenolic compounds on benzo[a]pyrene-induced neoplasia. Cancer Res. 1980, 40:2820-2823.
110. Wood A.W., Huang M.T., Chang R.L., Newmark H.L., Lehr R.E., Yagi H., Sayer J.M., Jerina D.M., Conney A.H. Inhibition of the mutagenicity of bay - region diol epox-ides of polycyclic aromatic hydrocarbons by naturally occurring plant phenol: exceptional activity of ellagic acid. Proc. Natl Acad. Sci, USA (Biochemistry) 1982, 79:5513-5517.
111. Yeretzian C., Jordan A., Lindnger W. Analysing the headspace of coffee by proton-transfer-reaction mass-spectrometry. Int. J. Mass Spectrometry 2003, 223-224:115-139.